3rd Quarter - Report

ARENTFOX SCHIFF LLP for INFECTIOUS DISEASES SOCIETY OF AMERICA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions

LobbyistCovered position, as disclosed
JON BOUKER —
STARSHINE CHUN —
BYRON DORGAN —
PHILIP ENGLISH —
JERI FREIRICH —
KELSEY GRISWOLD-BERGER —
CISSY JACKSON New Counsel and National Security Adviser, Sen. Doug Jones (2018-2021)
DAN RENBERG —
DANIEL SJOSTEDT —
OLIVER SPURGEON III —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2940 (118th), S. 1355 (118th), H.R. 4421 (118th), S. 2333 (118th), H.R. 4420 (118th)

Budget/Appropriations BUD

H.R. 9029 and S. 4942 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, regarding funding for programs dealing with antimicrobial resistance and infectious diseases, including Bio-Preparedness Workforce Pilot Program Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4942 (118th), H.R. 9029 (118th)

Medicare/Medicaid MMM

Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2025 Physician Fee Schedule

LobbyistCovered position, as disclosed
JON BOUKER —
BYRON DORGAN —
PHILIP ENGLISH —
JERI FREIRICH —
KELSEY GRISWOLD-BERGER —
DAN RENBERG —
OLIVER SPURGEON III —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.